Closing Bell: Hls Therapeutics Inc up on Wednesday (HLS)

Hls Therapeutics Inc opened trading today at $3.05 and closed at $3.05. It traded at a low of $3.05 to a high of $3.05.

The price boosted 1.33 percent from the previous day's close of $3.01.

During the day across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 2,600 on 11 total trades, with an average volume of 1,549 in the last five days.

The TSX market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $5.95 (August 09,2023) and low as $3.01 (August 06,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have shrunken -48.48 percent, while in 2024, they have shrunken -22.78%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $95.76 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc's average recommendation is "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..